Dr. Kowdley received his B.S. in Biology and Anthropology as a member of the Dean’s List at Columbia University, and his medical degree from Mount Sinai School of Medicine. He completed his internship and residency at Oregon Health Science University and a Fellowship in Gastroenterology and Hepatology at Tufts University School of Medicine. Dr. Kowdley is internationally recognized as a clinician, educator and researcher in the area of liver disease and has presented his research on liver diseases at more than 150 national and international meetings and scientific symposia. He is the author of more than 500 articles, book chapters, reviews and commentaries in this area.

Dr. Kowdley makes the following disclosures: 

• Consultant: CymaBay, Enanta, Genfit, Gilead, HighTide, Inipharm, Intercept, Madrigal, Mirum, NGM, Pfizer, 89bio
• Research Support: Corcept, CymaBay, Genfit, Gilead, GSK, Hanmi, Intercept, Madrigal, Mirum, Novo Nordisk, NGM, Pfizer, Pliant, Terns, Viking, 89bio
• Speaker Bureau: AbbVie, Gilead, Intercept
• Stock Options: Inipharm.